NCT01902342View on ClinicalTrials.gov

A Clinical Trial to Investigate the Influence of CES1 Polymorphism on Oseltamivir

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy
Interventions
DRUG

Oseltamivir 75 mg 1 cap

Trial Locations (1)

110-768

Seoul National University Hospital Clinical Trial Center, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01902342 - A Clinical Trial to Investigate the Influence of CES1 Polymorphism on Oseltamivir | Biotech Hunter | Biotech Hunter